SBI Securities’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Sell
1,022
-152
-13% -$3.48K ﹤0.01% 1529
2026
Q1
$25.9K Sell
1,174
-602
-34% -$10.5K ﹤0.01% 1352
2025
Q4
$20.9K Buy
1,776
+496
+39% +$6.37K ﹤0.01% 1425
2025
Q3
$20.3K Sell
1,280
-269
-17% -$3.9K ﹤0.01% 1446
2025
Q2
$17.7K Buy
1,549
+108
+7% +$1.22K ﹤0.01% 1461
2025
Q1
$19.5K Buy
1,441
+144
+11% +$2.39K ﹤0.01% 1338
2024
Q4
$21.9K Buy
+1,297
New +$25.2K ﹤0.01% 1303

Other funds holding CC

SBI Securities's CC Position: Q2 2026 in Review

SBI Securities reduced its Chemours (CC) stake by 13% in Q2 2026, selling an estimated $3.48K and leaving 1,022 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

SBI Securities first reported a position in CC in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.9K in Q1 2026. 471 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • SBI Securities held 1,022 shares of Chemours worth $21K as of Q2 2026.
  • SBI Securities sold 152 Chemours shares in Q2 2026, an estimated $3.48K.
  • Chemours made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1529 holding.
  • SBI Securities first reported a position in Chemours in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Chemours position peaked at $25.9K in Q1 2026.
  • 471 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.